220 related articles for article (PubMed ID: 35050952)
1. Intermittent Fasting in Weight Loss and Cardiometabolic Risk Reduction: A Randomized Controlled Trial.
Chair SY; Cai H; Cao X; Qin Y; Cheng HY; Ng MT
J Nurs Res; 2022 Feb; 30(1):e185. PubMed ID: 35050952
[TBL] [Abstract][Full Text] [Related]
2. Effects of alternate-day fasting on body weight and dyslipidaemia in patients with non-alcoholic fatty liver disease: a randomised controlled trial.
Cai H; Qin YL; Shi ZY; Chen JH; Zeng MJ; Zhou W; Chen RQ; Chen ZY
BMC Gastroenterol; 2019 Dec; 19(1):219. PubMed ID: 31852444
[TBL] [Abstract][Full Text] [Related]
3. Effects of time-restricted feeding in weight loss, metabolic syndrome and cardiovascular risk in obese women.
Schroder JD; Falqueto H; Mânica A; Zanini D; de Oliveira T; de Sá CA; Cardoso AM; Manfredi LH
J Transl Med; 2021 Jan; 19(1):3. PubMed ID: 33407612
[TBL] [Abstract][Full Text] [Related]
4. Effects of alternate-day fasting and time-restricted feeding in obese middle-aged female rats.
Bilibio BLE; Dos Reis WR; Compagnon L; de Batista DG; Sulzbacher LM; Pinheiro JF; Ludwig MS; Frizzo MN; Cruzat V; Heck TG
Nutrition; 2023 Dec; 116():112198. PubMed ID: 37717500
[TBL] [Abstract][Full Text] [Related]
5. Effect of alternate-day fasting on obesity and cardiometabolic risk: A systematic review and meta-analysis.
Park J; Seo YG; Paek YJ; Song HJ; Park KH; Noh HM
Metabolism; 2020 Oct; 111():154336. PubMed ID: 32777443
[TBL] [Abstract][Full Text] [Related]
6. Intermittent fasting two days versus one day per week, matched for total energy intake and expenditure, increases weight loss in overweight/obese men and women.
Arciero PJ; Arciero KM; Poe M; Mohr AE; Ives SJ; Arciero A; Boyce M; Zhang J; Haas M; Valdez E; Corbet D; Judd K; Smith A; Furlong O; Wahler M; Gumpricht E
Nutr J; 2022 Jun; 21(1):36. PubMed ID: 35658959
[TBL] [Abstract][Full Text] [Related]
7. Effect of time restricted feeding on anthropometric measures, eating behavior, stress, serum levels of BDNF and LBP in overweight/obese women with food addiction: a randomized clinical trial.
Irani H; Abiri B; Khodami B; Yari Z; Lafzi Ghazi M; Hosseinzadeh N; Saidpour A
Nutr Neurosci; 2024 Jun; 27(6):577-589. PubMed ID: 37436939
[TBL] [Abstract][Full Text] [Related]
8. Alternate day fasting for weight loss in normal weight and overweight subjects: a randomized controlled trial.
Varady KA; Bhutani S; Klempel MC; Kroeger CM; Trepanowski JF; Haus JM; Hoddy KK; Calvo Y
Nutr J; 2013 Nov; 12(1):146. PubMed ID: 24215592
[TBL] [Abstract][Full Text] [Related]
9. Interventions for weight loss in people with chronic kidney disease who are overweight or obese.
Conley MM; McFarlane CM; Johnson DW; Kelly JT; Campbell KL; MacLaughlin HL
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013119. PubMed ID: 33782940
[TBL] [Abstract][Full Text] [Related]
10. Intermittent fasting interventions for the treatment of overweight and obesity in adults aged 18 years and over: a systematic review protocol.
Jane L; Atkinson G; Jaime V; Hamilton S; Waller G; Harrison S
JBI Database System Rev Implement Rep; 2015 Oct; 13(10):60-8. PubMed ID: 26571283
[TBL] [Abstract][Full Text] [Related]
11. Diabetes Prevention and Weight Loss with a Fully Automated Behavioral Intervention by Email, Web, and Mobile Phone: A Randomized Controlled Trial Among Persons with Prediabetes.
Block G; Azar KM; Romanelli RJ; Block TJ; Hopkins D; Carpenter HA; Dolginsky MS; Hudes ML; Palaniappan LP; Block CH
J Med Internet Res; 2015 Oct; 17(10):e240. PubMed ID: 26499966
[TBL] [Abstract][Full Text] [Related]
12. Intermittent fasting interventions for treatment of overweight and obesity in adults: a systematic review and meta-analysis.
Harris L; Hamilton S; Azevedo LB; Olajide J; De Brún C; Waller G; Whittaker V; Sharp T; Lean M; Hankey C; Ells L
JBI Database System Rev Implement Rep; 2018 Feb; 16(2):507-547. PubMed ID: 29419624
[TBL] [Abstract][Full Text] [Related]
13. Effects of eight weeks of time-restricted feeding (16/8) on basal metabolism, maximal strength, body composition, inflammation, and cardiovascular risk factors in resistance-trained males.
Moro T; Tinsley G; Bianco A; Marcolin G; Pacelli QF; Battaglia G; Palma A; Gentil P; Neri M; Paoli A
J Transl Med; 2016 Oct; 14(1):290. PubMed ID: 27737674
[TBL] [Abstract][Full Text] [Related]
14. Whole-grain ready-to-eat oat cereal, as part of a dietary program for weight loss, reduces low-density lipoprotein cholesterol in adults with overweight and obesity more than a dietary program including low-fiber control foods.
Maki KC; Beiseigel JM; Jonnalagadda SS; Gugger CK; Reeves MS; Farmer MV; Kaden VN; Rains TM
J Am Diet Assoc; 2010 Feb; 110(2):205-14. PubMed ID: 20102847
[TBL] [Abstract][Full Text] [Related]
15. Effect of Various Types of Intermittent Fasting (IF) on Weight Loss and Improvement of Diabetic Parameters in Human.
Nowosad K; Sujka M
Curr Nutr Rep; 2021 Jun; 10(2):146-154. PubMed ID: 33826120
[TBL] [Abstract][Full Text] [Related]
16. Carbohydrate restriction in the morning increases weight loss effect of a hypocaloric Mediterranean type diet: a randomized, parallel group dietary intervention in overweight and obese subjects.
Dellis D; Tsilingiris D; Eleftheriadou I; Tentolouris A; Sfikakis PP; Dellis G; Karanasiou M; Meimari A; Dimosthenopoulos C; Lazarou S; Tentolouris N
Nutrition; 2020 Mar; 71():110578. PubMed ID: 31838462
[TBL] [Abstract][Full Text] [Related]
17. Effect of high-protein meal replacement on weight and cardiometabolic profile in overweight/obese Asian Indians in North India.
Gulati S; Misra A; Tiwari R; Sharma M; Pandey RM; Yadav CP
Br J Nutr; 2017 Jun; 117(11):1531-1540. PubMed ID: 28653586
[TBL] [Abstract][Full Text] [Related]
18. Effect of Alternate-Day Fasting on Weight Loss, Weight Maintenance, and Cardioprotection Among Metabolically Healthy Obese Adults: A Randomized Clinical Trial.
Trepanowski JF; Kroeger CM; Barnosky A; Klempel MC; Bhutani S; Hoddy KK; Gabel K; Freels S; Rigdon J; Rood J; Ravussin E; Varady KA
JAMA Intern Med; 2017 Jul; 177(7):930-938. PubMed ID: 28459931
[TBL] [Abstract][Full Text] [Related]
19. Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial.
Pi-Sunyer FX; Aronne LJ; Heshmati HM; Devin J; Rosenstock J;
JAMA; 2006 Feb; 295(7):761-75. PubMed ID: 16478899
[TBL] [Abstract][Full Text] [Related]
20. Meal timing during alternate day fasting: Impact on body weight and cardiovascular disease risk in obese adults.
Hoddy KK; Kroeger CM; Trepanowski JF; Barnosky A; Bhutani S; Varady KA
Obesity (Silver Spring); 2014 Dec; 22(12):2524-31. PubMed ID: 25251676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
